Novo Nordisk submitted an oral version of the weight-loss formulation of semaglutide (Wegovy) for FDA approval, according to ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Novo Nordisk now has an Ozempic pill. Citing a Novo spokesperson, pharmaceuticals news site BioPharmaDive reported yesterday ...

The World Vaccine Congress kicks off its annual conference this week in Washington, bringing together researchers, pharma ...

The FDA has approved the popular drug Dupixent (generic name, dupilumab) for adults and kids 12 and up with chronic spontaneous urticaria (CSU), a long-lasting itchy skin condition, when regular ...

The Trump administration is set to unveil a plan to remove petroleum-based synthetic dyes from the country’s food supply, ...

Novo Nordisk (NVO) asked the Food and Drug Administration to approve a pill version of its popular weight loss drug in obesity earlier this ...

A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Hikma has acquired the FDA-approved Abbreviated New Drug Application for trametinib tablets from Novugen. Hikma also has entered into a commercial agreement with Novugen where Hikma will be ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

He is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm ...